A Review of JAK Inhibitors for Treatment of Alopecia Areata in the Military Health Care System

    June 2024 in “ Military medicine
    Charles H. Song, Christopher Riley, Bart D Wilkison, Sunghun Cho
    Image of study
    TLDR JAK inhibitors like baricitinib and ritlecitinib are effective new treatments for severe alopecia areata.
    The review discusses alopecia areata (AA), an autoimmune condition causing patchy hair loss, and its impact on individuals, particularly within the military health care system. It highlights the introduction of baricitinib and ritlecitinib, JAK inhibitors recently approved by the FDA, as new treatment options for severe AA. The manuscript examines the disease's pathogenesis, its physical and psychological effects, and evaluates the efficacy and safety of these novel treatments compared to conventional therapies.
    Discuss this study in the Community →

    Research cited in this study

    23 / 23 results

    Related Community Posts Join

    6 / 1000+ results

    Related Research

    1 / 1 results